Editorial: thiopurines but not anti‐TNF monotherapy are linked to worse pregnancy outcomes in a large population‐based study
dc.contributor.author | Kinnucan, Jami | |
dc.contributor.author | Kane, Sunanda | |
dc.date.accessioned | 2021-08-03T18:17:45Z | |
dc.date.available | 2022-09-03 14:17:44 | en |
dc.date.available | 2021-08-03T18:17:45Z | |
dc.date.issued | 2021-08 | |
dc.identifier.citation | Kinnucan, Jami; Kane, Sunanda (2021). "Editorial: thiopurines but not anti‐TNF monotherapy are linked to worse pregnancy outcomes in a large population‐based study." Alimentary Pharmacology & Therapeutics (3): 343-344. | |
dc.identifier.issn | 0269-2813 | |
dc.identifier.issn | 1365-2036 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/168529 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Editorial: thiopurines but not anti‐TNF monotherapy are linked to worse pregnancy outcomes in a large population‐based study | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | |
dc.subject.hlbsecondlevel | Otolaryngology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/168529/1/apt16472_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/168529/2/apt16472.pdf | |
dc.identifier.doi | 10.1111/apt.16472 | |
dc.identifier.source | Alimentary Pharmacology & Therapeutics | |
dc.identifier.citedreference | Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013; 38: 501 – 512. | |
dc.identifier.citedreference | Bröms G, Granath F, Linder M, et al. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014; 20: 1091 – 1098. | |
dc.identifier.citedreference | Akbari M, Shah S, Velayos FS, et al. Systematic review and meta‐analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19: 15 – 22. | |
dc.identifier.citedreference | Meyer A, Drouin J, Weill A, Carbonnel F, Dray‐Spira R. Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti‐TNF: a French nationwide study 2010–2018. Aliment Pharmacol Ther. 2021; 54: 302 – 311. | |
dc.identifier.citedreference | Mahadevan U, Long MD, Kane SV, et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021; 160: 1131 – 1139. | |
dc.identifier.citedreference | Lee S, Seow CH, Adhikari K, et al. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Aliment Pharmacol Ther. 2020; 51: 544 – 552. | |
dc.identifier.citedreference | de Lima A, Zelinkova Z, Mulders AGMGJ, et al. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol. 2016; 14: 1285 – 1292.e1. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.